Magnetic resonance fingerprinting of the pancreas at 1.5 T and 3.0 T
Authors
Serrao, Eva M.
Kessler, Dimitri A.
Carmo, Bruno
Beer, Lucian
Brindle, Kevin M.
Buonincontri, Guido
Gallagher, Ferdia A.
Gilbert, Fiona J.
Godfrey, Edmund
Graves, Martin J.
McLean, Mary A.
Sala, Evis
Schulte, Rolf F.
Kaggie, Joshua D.
Publication Date
2020-10-16Journal Title
Scientific Reports
Publisher
Nature Publishing Group UK
Volume
10
Issue
1
Language
en
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Serrao, E. M., Kessler, D. A., Carmo, B., Beer, L., Brindle, K. M., Buonincontri, G., Gallagher, F. A., et al. (2020). Magnetic resonance fingerprinting of the pancreas at 1.5 T and 3.0 T. Scientific Reports, 10 (1) https://doi.org/10.1038/s41598-020-74462-6
Description
Funder: GlaxoSmithKline; doi: http://dx.doi.org/10.13039/100004330
Funder: National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre
Funder: Addenbrooke's Charitable Trust, Cambridge University Hospitals; doi: http://dx.doi.org/10.13039/501100002927
Abstract
Abstract: Magnetic resonance imaging of the pancreas is increasingly used as an important diagnostic modality for characterisation of pancreatic lesions. Pancreatic MRI protocols are mostly qualitative due to time constraints and motion sensitivity. MR Fingerprinting is an innovative acquisition technique that provides qualitative data and quantitative parameter maps from a single free‐breathing acquisition with the potential to reduce exam times. This work investigates the feasibility of MRF parameter mapping for pancreatic imaging in the presence of free-breathing exam. Sixteen healthy participants were prospectively imaged using MRF framework. Regions-of-interest were drawn in multiple solid organs including the pancreas and T1 and T2 values determined. MRF T1 and T2 mapping was performed successfully in all participants (acquisition time:2.4–3.6 min). Mean pancreatic T1 values were 37–43% lower than those of the muscle, spleen, and kidney at both 1.5 and 3.0 T. For these organs, the mean pancreatic T2 values were nearly 40% at 1.5 T and < 12% at 3.0 T. The feasibility of MRF at 1.5 T and 3 T was demonstrated in the pancreas. By enabling fast and free-breathing quantitation, MRF has the potential to add value during the clinical characterisation and grading of pathological conditions, such as pancreatitis or cancer.
Keywords
Article, /692/308/53/2421, /692/700/1421, article
Sponsorship
Cancer Research UK Cambridge Centre (CA685/A25177, CA685/A25177, CA685/A25177, CA685/A25177, CA685/A25177, CA685/A25177)
Horizon 2020 Framework Programme (761214)
Identifiers
s41598-020-74462-6, 74462
External DOI: https://doi.org/10.1038/s41598-020-74462-6
This record's URL: https://www.repository.cam.ac.uk/handle/1810/329544
Rights
Licence:
http://creativecommons.org/licenses/by/4.0/
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk